Location History:
- Lafayette, IN (US) (1998 - 2008)
- Edinburg, TX (US) (2009)
- College Station, TX (US) (2004 - 2011)
Company Filing History:
Years Active: 1998-2011
Title: Eva M Sevick-Muraca: Innovator in Biomedical Imaging
Introduction
Eva M Sevick-Muraca is a prominent inventor based in College Station, TX (US). She has made significant contributions to the field of biomedical imaging, holding a total of 10 patents. Her innovative work focuses on methods and systems that enhance the detection and imaging of lymph nodes and fluorescent targets.
Latest Patents
One of her latest patents is titled "Method and system for detecting sentinel lymph nodes." This invention involves introducing a fluorescent contrast agent into a lymph node system, directing near-infrared time-varying excitation light into the tissue, and generating a redshifted and time-varying emission light. The method allows for the detection and imaging of lymph nodes effectively. Another notable patent is "Method and system for near-infrared fluorescence contrast-enhanced imaging with area illumination and area detection." This invention describes a method for biomedical imaging that includes directing time-varying excitation light at a surface area of a light scattering material, detecting the resulting emission light, and generating a three-dimensional image of the fluorescent target.
Career Highlights
Eva has worked with esteemed organizations such as the Texas A&M University System and Purdue Research Foundation. Her work in these institutions has furthered the development of innovative imaging techniques that have significant implications in medical diagnostics.
Collaborations
Throughout her career, Eva has collaborated with notable colleagues, including Zhigang Sun and Huabei Jiang. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Eva M Sevick-Muraca is a trailblazer in the field of biomedical imaging, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to impact the medical community positively.